Inhaled Sedation in COVID-19-related Acute Respiratory Distress Syndrome (ISCA): an International Research Data Study in the Recent Context of Widespread Disease Resulting From the 2019 (SARS-CoV2) Coronavirus Pandemics (COVID-19)

NCT04383730 · clinicaltrials.gov ↗

COMPLETED

Status

203

Enrollment

OTHER

Sponsor class

Conditions

Critically Illness
Sedation
Invasive Mechanical Ventilation
Acute Respiratory Distress Syndrome

Interventions

DRUG: Intravenous sedation
DRUG: Inhaled sedation

Sponsor

University Hospital, Clermont-Ferrand

Collaborators

[object Object]
[object Object]
[object Object]